Ann: Leadership Changes and Strategic Review, page-10

Sorry PJ, I no longer hold shares and am a seller as I do not believe that even a miracle worker could recuresuscitate this company.

I reckon BVF are simply dollar cost averaging and hoping for the best.

A new CEO is essentially going to write off every intangible in sight.

All R&D will get written down to zero.

It will be a complete re-boot and therefore it will likely be a long time before the company has any new wonder drugs to spruik.

There are plenty of fish in the sea, so I would go look for another pretty girl and hope she can do more than just talk.

GLTA.